Clinicians caring for COVID-19 patients should be aware of the availability of these important life-saving medications and consider use when clinically indicated. When prescribing COVID-19 treatments, health care providers can use the following tools:
For an overview of mild to moderate COVID-19 outpatient therapies:
For the management of Paxlovid drug-drug-interactions:
To see what locations currently have COVID-19 therapeutics.
The Test to Treat program is a nationwide initiative launched by the federal government to ensure rapid access to no-cost COVID-19 oral medications for individuals who have tested positive for COVID–19, who are experiencing mild to moderate symptoms, and who are at high risk for severe disease including hospitalization and/or death. Test to Treat sites will provide COVID-19 tests, determine eligibility of COVID-19 patients to receive COVID-19 therapy, and prescribe medication that patients can fill on-site or at affiliated pharmacies.
During times of limited availability of therapeutic mediations, it is essential that all prescribers apply ethical principles in determining eligibility of these medications. Medications should only be prescribed in bonified clinician-patient relationships. Additional information on ethical principles during scarce resource allocations can be obtained through MDHHS.
